Bifidobacterium adolescentis CGMCC 15058 alleviates liver injury, enhances the intestinal barrier and modifies the gut microbiota in d-galactosamine-treated rats
Yating Li(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Lanjuan Li(Zhejiang University), Xianwan Jiang(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Huiyong Jiang(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Xiaoyuan Bian(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Jianzhong Ye(Zhejiang University), Longxian Lv(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Yan Ren(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Qing Wang(First Affiliated Hospital Zhejiang University), Jingjing Wu(Zhejiang University), Wenrui Wu(Shanghai Jiao Tong University), Liya Yang(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Cong‐Gao Peng(Wenzhou Central Hospital), Ding Shi(State Key Laboratory of Diagnosis and Treatment of Infectious Diseases), Daiqiong Fang(Zhejiang University)
Cited by 64
Related Papers
Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2016|2.1k
Clinical Findings in 111 Cases of Influenza A (H7N9) Virus Infection
|New England Journal of Medicine|2013|654
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
|Signal Transduction and Targeted Therapy|2023|592
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19)
|Clinical Infectious Diseases|2020|556